CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells

被引:266
作者
Schneider, Martin A.
Meingassner, Josef G.
Lipp, Martin
Moore, Henrietta D.
Rot, Antal [1 ]
机构
[1] Novartis Inst Biomed Res, A-1235 Vienna, Austria
[2] Max Delbruck Ctr Mol Med, Dept Mol Tumor Genet & Immunogenet, D-13125 Berlin, Germany
关键词
D O I
10.1084/jem.20061405
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CCR7-mediated migration of naive T cells into the secondary lymphoid organs is a prerequisite for their encounter with mature dendritic cells, the productive presentation of cognate antigen, and consequent T cell proliferation and effector differentiation. Therefore, CCR7 was suggested to play an important role in the initiation of adaptive immune responses. In this study, we show that primary immunity can also develop in the absence of CCR7. Moreover, CCR7-deficient knockout ( KO) mice display augmented immune responses. Our data cumulatively suggest that enhanced immunity in CCR7 KO mice is caused by the defective lymph node ( LN) positioning of FoxP3(+) CD4(+) CD25(+) regulatory T cells ( T reg cells) and the consequent impediment of their function. The FoxP3(+) T reg cells express CCR7 and, after their adoptive transfer, migrate into the LNs of wild-type mice. Here, they proliferate in situ upon antigen stimulation and inhibit the generation of antigen-specific T cells. Conversely, transferred CCR7-deficient T reg cells fail to migrate into the LNs and suppress antigen-induced T cell responses. The transfer of combinations of naive and T reg cells from wild-type and CCR7 KO mice into syngeneic severe combined immunodeficient mice directly demonstrates that CCR7-deficient T reg cells are less effective than their wild-type counterparts in preventing the development of inflammatory bowel disease.
引用
收藏
页码:735 / 745
页数:11
相关论文
共 54 条
[1]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[2]   How do CD4+CD25+ regulatory T cells control autoimmunity? [J].
Bluestone, JA ;
Tang, QZ .
CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (06) :638-642
[3]   Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics [J].
Bromley, SK ;
Thomas, SY ;
Luster, AD .
NATURE IMMUNOLOGY, 2005, 6 (09) :895-901
[4]   Dual role of CCR2 during initiation and progression of collagen-induced arthritis:: Evidence for regulatory activity of CCR2+ T cells [J].
Brühl, H ;
Cihak, J ;
Schneider, MA ;
Plachy, J ;
Rupp, T ;
Wenzel, I ;
Shakarami, M ;
Milz, S ;
Ellwart, JW ;
Stangassinger, M ;
Schlöndorff, D ;
Mack, M .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :890-898
[5]   B cells and professional APCs recruit regulatory T cells via CCL4 [J].
Bystry, RS ;
Aluvihare, V ;
Welch, KA ;
Kallikourdis, M ;
Betz, AG .
NATURE IMMUNOLOGY, 2001, 2 (12) :1126-1132
[6]   Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4 T cell-dendritic cell interaction [J].
Castellino, F ;
Huang, AY ;
Altan-Bonnet, G ;
Stoll, S ;
Scheinecker, C ;
Germain, RN .
NATURE, 2006, 440 (7086) :890-895
[7]   Visualizing the first 50 Hr of the primary immune response to a soluble antigen [J].
Catron, DM ;
Itano, AA ;
Pape, KA ;
Mueller, DL ;
Jenkins, MK .
IMMUNITY, 2004, 21 (03) :341-347
[8]   Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals [J].
Cavani, A ;
Nasorri, F ;
Ottaviani, C ;
Sebastiani, S ;
De Pità, O ;
Girolomoni, G .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5760-5768
[9]   Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs [J].
Cyster, JG .
ANNUAL REVIEW OF IMMUNOLOGY, 2005, 23 :127-159
[10]   Frontline:: Generalized multi-organ autoimmunity in CCR7-deficient mice [J].
Davalos-Misslitz, Ana C. M. ;
Rieckenberg, Julia ;
Willenzon, Stefanie ;
Worbs, Tim ;
Kremmer, Elisabeth ;
Bernhardt, Guenter ;
Foerster, Reinhold .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (03) :613-622